Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer

Abstract

Jia-Yang Lu and Zhu Lin contributed equally to this work.Objective: To optimize the flattening filter-free (FFF) beam selection in stereotactic body radiotherapy (SBRT) treatment for Stage I lung cancer in different fraction schemes. Methods: Treatment plans from 12 patients suffering from Stage I lung cancer were designed using the 6XFFF and 10XFFF beams in different fraction schemes of 4 3 12, 3 3 18 and 1 3 34 Gy. Plans were evaluated mainly in terms of organs at risk (OARs) sparing, normal tissue complication probability (NTCP) estimation and treatment efficiency.Results: Compared with the 10XFFF beam, 6XFFF beam showed statistically significant lower dose to all the OARs investigated. The percentage of NTCP reduction for both lung and chest wall was about 10% in the fraction schemes of 4 3 12 and 3 3 18 Gy, whereas only 7.4% and 2.6% was obtained in the 1 3 34 Gy scheme. For oesophagus, heart and spinal cord, the reduction was greater with the 6XFFF beam, but their absolute estimates were ,10 26 %. The mean beam-on time for 6XFFF and 10XFFF beams at 4 3 12, 3 3 18 and 1 3 34 Gy schemes were 2.2 6 0.2 vs 1.5 6 0.1, 3.3 6 0.9 vs 2.0 6 0.5 and 6.3 6 0.9 vs 3.5 6 0.4 min, respectively. Conclusion: The 6XFFF beam obtains better OARs sparing and lower incidence of NTCP in SBRT treatment of Stage I lung cancer, whereas the 10XFFF beam improves the treatment efficiency. To balance the OARs sparing and intrafractional variation owing to the prolonged treatment time, the authors recommend using the 6XFFF beam in the 4 3 12 and 3 3 18 Gy schemes but the 10XFFF beam in the 1 3 34 Gy scheme. Advances in knowledge: This study optimizes the FFF beam selection in different fraction schemes in SBRT treatment of Stage I lung cancer. INTRODUCTIONLung cancer is the first and second leading cause of cancer death both in males and females, respectively, accounting for 13% of the total cases and 18% of deaths in 2008.

FFF‐VMAT for SBRT of lung lesions: Improves dose coverage at tumor‐lung interface compared to flattened beams

“…Combining FFF‐beams with volumetric modulated arc therapy (VMAT) results in even greater treatment efficiency for complex lung SBRT plans compared to historically used 8–15 noncoplanar fixed fields or several noncoplanar dynamic conformal arc (DCA) plans. Linac‐based intensity modulated radiation therapy (IMRT), helical TomoTherapy or optimized robotic CyberKnife treatments significantly prolong SBRT treatment time, comparatively …”

Clinical impact of the flattening filter free irradiation in fixed-field IMRT and VMAT for stage I–II nasal natural killer/T-cell lymphoma

“…Without a flattening filter (FF) in the beam path, FFF irradiation offers an opportunity to lower the out-of-field dose and delivers radiation doses with high dose rate and high efficiency (Dobler et al, 2017;Georg et al, 2011;Kragl et al, 2011). FFF irradiation reduces delivery times in stereotactic treatments and lowers the secondary cancer risk in peripheral organs, which has been confirmed by many researches (Dobler et al, 2017;Lu et al, 2015;Murray et al, 2015;Scorsetti et al, 2014;Swamy et al, 2015).…”

A simple, yet novel hybrid‐dynamic conformal arc therapy planning via flattening filter‐free beam for lung stereotactic body radiotherapy

“…Recently, there has been growing interest in the clinical use of flattening filter free (FFF) beams to deliver lung SBRT treatment. [14][15][16][17][18] FFF-beams have much higher dose rates compared to traditional flattened-beams that use flattening filters (FF). FFF beams can reduce beam on time (specifically beneficial for single large dose treatment), resulting in better patient comfort and reducing dose delivery uncertainty due to less intrafraction motion error and can potentially reduce out-of-field dose with less head scatter and electron contamination.…”